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ABSTRACT 
 
Probiotics have been demonstrated to promote growth, stimulate immune 
responses, and improve the microbial food safety of poultry.  While widely used, their 
effectiveness is mixed and the mechanisms through which they contribute to poultry 
production are not well understood.  Phytases isolated from microorganisms are 
increasingly supplemented in feed to improve digestibility and reduce anti-nutritive 
effects of phytate.  The microbial origin of these enzymes suggests a potentially 
important mechanism of probiotic functionality. 
Our objective was to investigate phytate degradation as a novel probiotic 
mechanism using recombinant Lactobacillus cultures expressing Bacillus subtilis 
phytase.  B. subtilis phyA was codon optimized for expression in Lactobacillus and 
cloned into the expression vector, pTRK882.  The resulting plasmid, pTD003, was 
transformed into Lactobacillus acidophilus, Lactobacillus gallinarum, and Lactobacillus 
gasseri. SDS-PAGE revealed an approximately 44 kDa protein in the culture 
supernatants of Lactobacillus pTD003 transformants corresponding to the predicted 
molecular weight of B. subtilis phytase. The phytate degrading ability of these cultures 
was evaluated by determining the amount of inorganic phosphate released from sodium 
phytate. Expression of B. subtilis phytase increased phytate degradation of L. 
acidophilus, L. gasseri, and L. gallinarum approximately 4-, 10-, and 18-fold over the 
background activity of empty vector transformants.  
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The effect of administration of recombinant phytase-expressing L. gallinarum 
and L. gasseri was evaluated in broiler chicks fed a phosphorous deficient diet (0.25% 
aP). Phytase-expressing L. gasseri improved weight gain (P < 0.05) of broiler chickens 
to a level comparable to chickens fed a phosphorous adequate control diet (0.40% aP) 
demonstrating proof of-principle that administration of phytate-degrading probiotic 
cultures can improve performance of livestock animals. Additionally, this will inform 
future studies investigating whether probiotic cultures are able to combine the 
performance benefits of feed enzymes with the animal health and food safety benefits 
traditionally associated with probiotics. 
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CHAPTER I 
INTRODUCTION OF ALTERNATIVES TO ANTIBIOTIC GROWTH 
PROMOTERS 
 
1.1 INTRODUCTION   
Antibiotics have been used to promote the growth of broiler chickens and other 
livestock animals in the United States for more than 50 years (1-3). Antibiotics are 
known to increase weight gain (1), improve feed efficiency (4, 5), and reduce mortality 
in livestock animals (6, 7). However, the use of antibiotic growth promoters (AGPs) is in 
decline because of consumer preferences and regulatory concerns (8).  The development 
of antibiotic resistant microorganisms is of particular concern (9).  In 1969 the British 
Government issued a report detailing the discovery of Salmonella enterica Typhimurium 
resistance to the antibiotic oxytetracycline (10).  The committee recommended halting 
the use of streptomycin, oxytetracycline, and penicillin for sub-therapeutic use in order 
to reduce the occurrence of resistant pathogens (10).  In 1986, Sweden became the first 
country to ban AGPs after consumer confidence dropped due to the abundant use of 
antibiotics and concerns over food safety (11, 12). Denmark followed Sweden in 
banning AGPs in 1998 (8).  
After bans in Sweden and Denmark, the European Union (EU) banned use of 
antibiotic growth promoters starting with Avoparcin in 1997.  All non-therapeutic 
antibiotic use in livestock was eventually banned across the  EU by 2006 (13).  
Consequences of the AGP ban has been reported in Denmark (4, 14).  The Danish 
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poultry industry experienced a significant increase in necrotic enteritis, from one flock in 
1997 to 25 flocks the following year after the food animal industries decided to 
voluntarily ban AGPs in order to be completely AGP free by 1999 (14).  Feed 
conversion ratio has also increased after removal of AGPs (4).  The reduction of AGP 
use in the swine industry has led to dietary zinc deficiencies (15).   
Several alternatives to AGPs are currently being used by livestock producers.  
Some of these alternatives include non-starch polysaccharide-degrading enzymes known 
as NSPases (16) and the phytate degrading enzymes, phytases (17).  These enzymes are 
administered to livestock animals to aid in the digestion of indigestible feed constituents 
(18).  Other alternatives to AGPs are probiotic microorganisms, including Lactobacillus, 
Bacillus, and Enterococcus species (19).  Additional alternatives include prebiotic 
oligosaccharides and organic acids (19).  These AGP alternatives alter the 
gastrointestinal microbiota of livestock animals, promoting  immune development and 
reducing pathogen colonization (19).  
1.2 ANTIBIOTIC GROWTH PROMOTERS 
1.2.1 AGP Use in Poultry 
 The growth promotion effects of antibiotics on broiler chickens were first 
demonstrated by Moore et al. (1) Broiler chicks were fed showed streptomycin increased 
growth when compared to broilers not fed streptomycin (1).  Because of the evidence of 
growth promotion by antibiotics in poultry, the United States Food and Drug 
Administration has allowed the non-therapeutic use of antibiotics for growth promotion 
in animal feed since 1951 (20, 21).  AGPs have helped the poultry industry to produce 
 3 
 
healthy broiler chickens while reducing costs of therapeutic treatments and economic 
loss from massive flock mortality (22).  While AGPs promote growth of livestock 
animals, they are also known to select for antibiotic resistant variants of microorganisms. 
Coliform bacteria were observed to mutate and become resistant in poultry where 
streptomycin was administered (23, 24).  The fear of bacterial infections becoming more 
resistant to treatment has resulted in the banning of AGPs in Europe (8).  Furthermore, 
resistant strains of human pathogens have developed due to  the use of AGPs for the past 
50 years (9).  These pathogenic strains are more difficult to treat due to the fact that they 
are currently highly resistant to an array of antibiotics and the patients must undergo 
longer periods of antibiotic treatments to ensure destruction of the pathogen (9). 
1.2.2 Mechanisms of Antibiotics in Growth Promotion 
The gastrointestinal microbiota is thought to decrease host performance through 
reduced intestinal absorption of nutrients, direct competition for nutrients with the host, 
production of growth depressing metabolites, and sub-clinical infection (25, 26).  AGPs 
have been shown to modify the gastrointestinal microbiota of livestock animals (27, 28), 
reducing its negative effect on host performance. 
When AGPs are introduced to the intestine, availability of nutrients increases.  It 
is believed that antibiotics also reduce the overall microbial population, which induces 
the thinning of the small intestine and increase in the thickness of the muscosa.  The 
reduction of pathogens and their antimetabolites results in better nutrient absorption, 
which improves the growth and feed efficiency of the livestock animal (9, 29). 
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Colonization of poultry by pathogens including Clostridium perfringens is 
known to depress growth rates in chickens reducing the overall productivity of broiler 
flocks (30).  Inflammation in response to sub-clinical infection with C. perfringens 
causes the release of catabolic hormones, resulting in a reduction of muscles mass (31).  
AGPs reduce pathogen populations with little impact to commensal bacteria (32) 
reducing growth depression due to sub-clinical infection.  Additionally, C. perfringens 
has been implicated in necrotic enteritis (NE) pathology in chickens (33). The disease 
can decimate broiler flock populations (33) result in mortality of at least 30%. 
By altering the microbiota, AGP reduce the production of growth suppressing 
microbial metabolites.  Organisms like Bacillus spp., Salmonella spp., Campylobacter 
spp., Pseudomonas, and Escherichia coli while not pathogenic in chickens produce 
toxins that are strong chelating agents.  Siderophores produced by both Gram-positive 
and Gram-negative microorganisms including Salmonella, Staphylococcus aureus and E. 
coli (34-36) are highly destructive compounds produced by bacteria and possess 
powerful binders have a high affinity for the metal ion iron (37). Once iron is 
sequestered from the host, cellular function is disrupted, resulting in apoptosis and 
necrosis of host cells.  Pyocyanine, pyoverdin produced from Pseudomonas (38).  AGPs 
known to inhibit pathogens like Staphylococcus and Campylobacter are administered to 
the livestock animal, theoretically reducing the amount of undesirable harmful bacteria 
in the microbiota population of the animal.  
As a result, the remaining microbial population in the animal has a smaller 
impact in reducing available nutrients to the animal. The reduced competition for 
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nutrients from microorganism in the gastrointestinal tract ideally results in animals that 
are healthier and better able to absorb nutrients previously utilized by undesirable 
microorganisms.  With the reduction of undesirable microbes in the chicken’s intestinal 
tract, the intestinal villi of the gut wall is altered (39, 40) by thinning the small intestinal 
barrier, allowing for improved nutrient absorption.  With the improvement on nutritional 
uptake, improved feed efficiency occurs, producing chickens that grow faster. 
1.2.3 AGP Resistant Microorganisms 
Antibiotics that are commonly used in treating bacterial infections found in 
humans are sometimes used as AGPs in poultry.  These shared antibiotics are penicillin, 
tetracycline, and erythromycin (20). This is a cause for concern because the antibiotic 
resistant bacteria found in livestock animals can be zoonotic.  Campylobacter (41, 42) 
and Salmonella (43, 44) are pathogens found in poultry reservoirs, they are also two of 
the most common foodborne pathogens infecting humans (45).   
Even though the United States has yet to ban AGPs, the European Union has 
banned AGPs in livestock for years.  The first country to do so was Sweden in 1986 
(12), Sweden lead Europe in the removal of AGPs due to the findings of antibiotic 
resistant pathogens.  In the early 90’s other European countries like Germany, Denmark 
and Finland followed Sweden’s stance on AGPs and banned antibiotics used in animals 
feeds, particularly the antibiotics involved in human medicine.  These countries banned 
glycopeptides, spiramycin and virginiamycin use as AGPs due to their significance in 
treating disease in humans.   
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1.3 FEED ADDITIVE ENZYMES  
  Used in feed more than 80% of poultry feed the United States, feed additive 
enzymes are the most widely used alternative to AGPs (46).  The inability of 
monogastric animals to fully digest plant-based feeds is well known (47).  Exogenous 
enzyme increase available nutrients to the animal by hydrolyzing indigestible feed 
constituents, while reducing the anti-nutritive effects of plant based feeds constituents. It 
is accepted that enzymes reduce the viscosity in the gastrointestinal tract, allowing for an 
increase rate of passage (48-51).  
Feed enzymes in poultry were used in Europe well before they were used in the 
United States.  Interest in feed enzymes resulted from changing attitudes towards drug 
and antimicrobial use in food and the abundance of cheap feed ingredients (46).  The 
majority currently used feed enzymes come from Bacillus spp. and Aspergillus spp (52).  
Poor nutrient uptake and feed conversion from the presence of indigestible feed 
constituents is improved with the addition of exogenous enzymes.  Reducing the 
undesirable effects of indigestible feed constituents reduces the amount of money and 
resources exhausted on producing an animal, while at the same time providing a ample 
and healthier animal (53).  
1.3.1 NSPases 
The nutritional benefit impact of feed made up of oats, barley, rye, and wheat 
have been underutilized because of the indigestible feed constituent, non-starch 
polysaccharides (NSP) (54).  Rye and barley based diets are known to exert anti-
nutritive effects and alter the microbiota in early growth of poultry (55-57).  These non-
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digestible feed constituents interfere with nutritional value, restricting vitamins and other 
nutrients essential in development.  With the supplementation of NSPase to poultry 
diets, an improvement to the nutritional value and digestibility of grain based feeds 
containing complex polymers was seen (17, 58).  The particular aim of the enzyme use 
was to hydrolyze with specific non-starch polysaccharides, producing a digestible energy 
source.  Monogastric animals cannot produce enzymes capable of breaking down the 
non-starch polysaccharides like cellulose, arabionoxylan, and β-glucans which sequester 
desired nutrients (59).  With the addition of enzymes in feed, the anti-nutrient properties 
of oats, barley, and wheat are diminished.  The reduction of anti-nutritive properties and 
the improved intestinal viscosity allows for of improved nutrient absorption.  Improved 
growth can be seen in broilers due to the increase of digestible energy along with the 
reduction of sequestered nutrients, (49, 60, 61). 
The latest enzymes used in the feed industry are β-Glucanases and Xylanases 
(59). These NSPase enzymes break down the complex polysaccharides glucan and xylan 
found in plant cell walls and turn otherwise indigestible polysaccharides into digestible 
carbohydrates for energy.  Though these enzymes are still used, the focus of enzymatic 
use in the feed industry has shifted to phosphatases.   
1.3.2 Phytases 
Phosphorous is an essential nutrient in poultry production (62) with dietary 
deficiencies leading to excessive financial losses due to increased mortality (63, 64). 
Phytic acid (myo-inositol hexaphosphate) is an important plant phosphorus storage form 
and accounts for 50 - 80 % of total phosphorus present in cereal grains and legumes 
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commonly used in livestock animal feeds (65, 66).  However, phytate-phosphorous has 
low bioavailability and is underutilized due to the indigestibility of phytic acid in non-
ruminant livestock, including poultry (67, 68) and swine (69).  Additionally, phytic acid 
exerts anti-nutritive effects (63), sequestering essential cations including calcium, 
magnesium, iron, and zinc, reducing their bioavailability (70). 
Phytase is a particular phosphatase enzyme originally derived from Aspergillus 
fumigates, with the ability to increase the inorganic phosphate absorption by the 
hydrolysis of phytic acid found in plant based feeds (71).Phytases are phosphatases 
which catalyze the hydrolysis of phytic acid to myo-inositol and inorganic phosphate 
(72).  In-feed administration of microbial phytases to improve digestibility of phytic acid 
is widely used in the production of poultry and other livestock (73, 74).  There are 
several classes of phytases including histidine acid phosphatases,  β-propeller phytases, 
purple acid phosphates, and cysteine phosphatases (75).  Most commercial phytases used 
currently in livestock agriculture are histidine acid phosphatases from E. coli and fungi 
(18). 
Bacterial β -propeller phytases from the Bacillus species are an alternative to the 
enzymes used from the histidine acid phosphatase group (18). Bacillus phytase is a β-
propeller phytase containing a six-bladed propeller fold architecture (76). The Bacillus 
phytases have a high thermal stability, and a calcium phytate complex with a neutral pH 
range.  Phytase activity is dependent on the pH range of the host’s gastrointestinal tract, 
which is why not all phytases are suitable for every animal in agriculture.  Bacillus 
phytases are being closely examined for application in the pelleting processes of feed, 
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due to their high heat tolerance (77).  Another desirable quality of Bacillus subtilis 
phytase is some strains, like Bacillus subtilis 168, are already used in fermentation of 
food (78) and is generally recognized as safe.   
1.4 OTHER ALTERNATIVES 
1.4.1 Prebiotics 
Prebiotics are non-digestible compounds that benefit the host by selectively 
stimulating the growth and/or activity of one or a limited number of bacteria in the 
colon, thus improving the host’s health (79).  In order to be considered a prebiotic, the 
feed ingredient cannot be hydrolyzed or absorbed in the upper gastrointestinal tract. It 
must be a selective substrate to a limited amount of commensal organisms, and must 
alter the microbiota of the host towards a healthy composition (80).  Oligosaccharides 
including galacto-oligosaccharide, inulin, and lactulose have been found to stimulate 
beneficial intestinal microbes (81, 82). 
 One of the steps in the infection process is when pathogenic bacteria colonize the 
mucosal tissue.  Prebiotics can be used in chickens to reduce colonization of pathogenic 
bacteria.   When administered to Salmonella Typhimurium challenged broilers, a 25-fold 
decrease in was observed in broilers administered prebiotic mannan oligosaccharide 
compared to broilers not given the prebiotic (83).  This prebiotic is believed to help in 
the prevention of Salmonella Typhimurium adherence to the intestinal wall, while not 
affecting the adherence of Lactobacillus and Enterococcus. 
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1.4.2 Organic Acids 
Another alternative to AGPs is the use of organic acids in feed.  Organic acid is 
known to increase energy contribution to feed and improve protein digestion by the 
increasing pepsin activity (48, 84).  Organic acids have been able to reduce levels of 
Salmonella (85) and Campylobacter jejuni (86) in chickens.  Although the mechanisms 
of organic acids are not completely understood, organic acids are able to exhibit 
bactericidal properties to certain microorganisms (87).  It is believed that these acids 
lower the gastrointestinal pH of the animal allowing organic acids to penetrate across the 
lipid membrane and reduce bacterial growth by changing the internal pH and interfering 
with cellular function (87).   
1.5 PROBIOTICS 
Probiotics are living microorganisms that when administered in adequate 
amounts, confer beneficial health effects upon the host (88).  Most of these probiotic 
microorganisms fall under the category of Lactic acid bacteria (LAB), some LAB can 
aid in the physiological functions of the gastro intestinal tract, including immune system 
stimulation, improve nutritional bioavailability, and restoration of mucosal layer (89). 
 The objective of these alternatives to AGPs is to improve the gastro intestinal 
health by influencing the commensal microflora in intestine of the livestock animal (48).  
Microflora of the animal can be successfully manipulated to inhibit or competitively 
exclude pathogens, while at the same time providing enhanced growth performance by 
enabling the additional probiotic mechanisms that increase nutritional absorption within 
the gastro intestinal tract. 
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1.5.1 Probiotic Benefits  
Humans and animals alike have key inhabitants in the gastrointestinal tract that 
play essential roles in health.  The probiotic Lactobacillus has multiple functions that are 
not just limited to food fermentation.  Lactobacillus also provides pathogen exclusion, 
bioactive materials, and regulations of gastro intestinal health.  The ability of 
Lactobacillus to be used in functional foods as a health related product is growing. The 
breakthrough of the nomenclature of Lactobacillus has allowed for the broadening of the 
amount of Lactobacillus available in research. This allows for the ability to pinpoint 
certain strains to perform more ideally for in vitro research.  It is critical to understand 
the roles, mechanisms and interactions of each unique species of Lactobacillus used as 
probiotics.  Genetic characterization and the ability to manipulate the functions of 
Lactobacillus allow for the use of expression vectors to provide additional benefits to the 
host, and expand the potential uses of probiotic organisms (90).  
1.5.2 Probiotic Benefits to Poultry Health 
 LAB Probiotics like Lactobacillus, Enterococcus and Streptococcus can be 
considered beneficial and can be used as health-promoting functional food ingredients.  
Intestinal pathogens are susceptible to many of the defenses LAB probiotics produce.  
LAB production of lactic acid and bacteriocins inhibits the growth of pathogens found in 
poultry, such as Salmonella (91) and Campylobacter (92).  The lactic acid produced by 
LAB effectively lower the pH of the gastrointestinal environment, slowing the growth of 
non-commensal organisms competing for nutrients.  The ability to increase resistance to 
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disease and effectively reduce the need of antibiotics in livestock has made LAB an ideal 
probiotic organism (19).   
1.5.3 Probiotic Mechanisms 
The mechanisms behind these physiological functions are not fully understood; 
nevertheless specific benefits are connected with probiotics’ ability to modify the gut 
microbiota within the host. This prevents pathogen adherence by producing bacteriocins 
in order to keep healthy intestinal function (93).  Probiotics introduced to chickens early 
in rearing, should edge out, or at least reduce the amount of undesirable organisms. The 
reduction of pathogens could lessen the chance of human contact with these pathogens, 
while at the same time producing a healthier chicken.  Prior to hatch, the chick’s 
intestinal tract is sterile, however, it is quickly colonized by facultative anaerobes like 
Listeria and Salmonella (94).  For best results, probiotics are introduced early in the 
rearing process as possible.  Even with early administration, undesirable microbes could 
possibly colonize a different part of the GI tract. Because of this, a cocktail of multiple 
probiotic strains known to colonize in different parts of the GI tract may be needed in 
order to successfully reduce undesirable microbes.  This method would be instrumental 
in providing three key benefits to the host animal.  One would be the resistance to 
pathogenic and nonindigenous microbes by competitive exclusion (95).  The second 
would be the stimulation of the host’s defenses, by developing the mucosal layer, 
epithelial layer, and the lamina propria throughout the GI tract. A healthy mucosal layer 
will segregate normal healthy microbes and assist in keeping pathogenic microbes away 
from animal tissue.  Within the epithelium tissue and lamina propria, a healthy 
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abundance of immune cells will provide defenses against pathogens that get past the 
mucosal layer (96).  The third benefit would be microflora-secreted nutrients. These 
nutrients excreted by the beneficial microflora can provide amino acids, vitamins and 
short chain fatty acids.  These fatty acids will help provide a energy supply for the 
growing broiler and will reduce the amount of undesirable microbes in the ceca of the 
broiler (9, 97). 
New uses of probiotics are constantly being examined.  Recent studies pertaining 
to identifying the possible mechanisms of probiotics suggest the ability to improve 
immune system of hosts (98, 99),  with the possibility of treatments for  chronic bowl 
disease diseases like Crohn’s and ulcerative colitis (100, 101), colon cancer (102) and 
bladder cancers (93, 103).  Additional novel mechanisms of probiotics is targeted 
enzyme delivery for improved feed utilization (104, 105), and vaccine delivery (106) in 
prevention of diseases.  
The probiotic functionality that results in the benefits that increase overall health 
of broilers and monogastric animals may not be new, but it is certainly of great 
significance. The ability to introduce or control the microflora of agricultural animals 
would not only benefit the development of the animal, but also it would benefit 
marketing the animal to consumers.  To be able to tell consumers that the animal product 
they purchase at the super market had healthy microbiota, and that it was raised 
antibiotic free would be a huge selling point.  The ability to administer microbes as a 
simple probiotic could possibly solve many nutritional and industrial needs. 
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1.6 CONCLUSION 
It is possible that the United States may follow the European Union and ban non-
therapeutic use of antibiotics.  The development of zoonotic pathogenic from animal 
reservoirs through the use of AGPs is of great concern.  Pathogenic bacteria are already 
becoming resistant to vancomycin which regularly used in hospitals used for antibiotic 
chemotherapy (107, 108).  The risk associated with drug resistant strains due to the AGP 
use will continue to be debated in United States.   
Alternatives to AGPs including feed additives enzymes, organic acids, prebiotics 
and probiotics will be important for the poultry industry future in order to keep 
performance promotion levels to the equivalence of AGPs. The ability to provide 
alternatives to AGPs can be a reasonable solution to the hurdles facing the poultry 
industry. Feed utilization, anti-nutritional properties, pathogenic bacteria and 
gastrointestinal health are all problems that can be seemly solved with the introduction 
feed additives, prebiotics, and probiotic cocktails. These alternatives are able to deliver 
additional enzymes that can degrade non-starch polysaccharides and other indigestible 
feed constituents that have anti-nutritional properties. While at the same time, keep 
pathogens from adhering to intestinal tract of the host.  The utility that probiotics bring is 
incredibly advantageous; the ability to solve multiple problems with one organism that is 
recognized as safe is of utmost value.  
Probiotics are expected to be a particularly important alternative to AGPs.  These 
microorganisms could possibility provide all the needed healthy mechanisms needed for 
growth promotions in livestock.  The ability to improved digestion, competitive 
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exclusion, and immune response makes probiotics a viable alternative to antibiotics.  
This will allow for the host to be able to utilize nutrients that were not regularly 
available prior to ingesting probiotics.  Some probiotics like Lactobacillus  are capable 
of delivering vectors, vaccines and biotherapeutics to chickens and other animals (109).  
It is possible that these probiotics could have the ability to synthesize digestive enzymes.  
Lactobacillus and other LAB are ideal organisms to be used in future research due to 
these synergetic benefits.  The potential of being able to provide probiotics with the 
capability of hydrolyzing non-starch polysaccharides and phytic acid found in feed into a 
useable source of nutrition would greatly improve feed utilization, without sacrificing 
the health of the animal.   
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CHAPTER II 
ADMINISTRATION OF PHYTATE-DEGRADING LACTOBACILLUS 
IMPROVES GROWTH OF BROILER CHICKENS 
 
2.1 INTRODUCTION 
Lactobacillus species are important inhabitants of the gastrointestinal tract of 
humans and animals and are increasingly being used as probiotic microorganisms due to 
their health promoting properties (82, 110).  Probiotics, sometimes called Direct Fed 
Microbials (DFM) when used in animals (111), are live microorganisms administered to 
confer a health benefit upon the host (112).  Administration of probiotic Lactobacillus to 
poultry has been demonstrated to promote growth at levels similar to antibiotics (113, 
114) and reduce gastrointestinal colonization of human food borne pathogens including 
Campylobacter (115, 116), Clostridium (117), and Salmonella (118, 119).  Because of 
concern over antibiotic resistant pathogens and pressure from both consumers and 
regulatory agencies, probiotics have received increased interested as potential 
alternatives to antibiotic growth promoters (120).  While probiotics are used widely 
across the livestock industry (121), their effectiveness is varied and, the mechanisms 
responsible for their benefits are not well understood. 
Phosphorus is an essential nutrient in poultry production (62) with dietary 
deficiencies leading to excessive financial losses due to increased mortality (63, 64).  
Phytic acid (myo-inositol hexaphosphate) is an important plant phosphorus storage form 
and accounts for 50 - 80 % of total phosphorus present in cereal grains and legumes 
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commonly used in livestock animal feeds (65, 66).  However, phytate-phosphorus has 
low bioavailability and is underutilized due to the poor digestibility of phytic acid in 
non-ruminant livestock including poultry (67, 68) and swine (69).  Additionally, phytic 
acid exerts anti-nutritive effects (63), sequestering essential cations including calcium, 
magnesium, iron, and zinc and reducing their bioavailability (70). 
Phytases are phosphatases which catalyze the hydrolysis of phytic acid to myo-
inositol and inorganic phosphate (72).  In-feed administration of microbial phytases to 
improve digestibility of phytic acid is widely used in the production of poultry and other 
livestock (73, 74).  The resulting increases in phytate-phosphorus digestibility (17, 63, 
122) and reduction in the anti-nutritive effects (123, 124) of phytic acid are well 
documented.  The microbial origin of phytases used in livestock production suggests 
degradation of phytic acid may be a potentially important mechanism of probiotic 
functionality.  Combining the nutritional and performance benefits of phytase with the 
food safety and animal health benefits traditionally associated with probiotics is of great 
interest to livestock producers.  In this study, we investigated phytate degradation as a 
novel mechanism of probiotic functionality.  Recombinant Lactobacillus cultures 
expressing B. subtilis phytase were constructed and, the effect of their administration on 
growth performance was evaluated in broiler chicks fed a phosphorus deficient diet.  We 
demonstrate proof-of-principle that administration of a phytate-degrading probiotic 
culture can improve the performance of livestock animals 
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2.2 MATERIAL AND METHODS 
2.2.1 Bacterial Strains, Plasmids, and Growth Conditions 
The bacterial strains and plasmids used or constructed in this study are listed in 
Table 1.  Lactobacillus strains were cultured using deMan, Rogosa, and Sharpe (MRS) 
medium (Difco, Franklin Lakes, NJ) and incubated in 10% CO2 at 37°C with 5 µg/ml 
erythromycin (Erm; EMD Chemicals, Inc., San Diego, CA) added when appropriate.  
Escherichia coli strains were cultured using Luria-Bertani (LB) medium (Difco, Franklin 
Lakes, NJ) aerobically at 37°C with 150 µg/ml Erm, when appropriate. 
2.2.2 DNA Isolation, Manipulation, and Transformation   
E. coli plasmid DNA was isolated using the QIAprep Spin Miniprep kit 
(QIAGEN Inc., Valencia, CA), while DNA was isolated from Lactobacillus according to 
the method of Walker and Klaenhammer (125).  DNA restriction fragments were 
purified from agarose gels using the QIAquick Gel Extraction Kit (QIAGEN, 
Germantown, MD).  All manipulations were performed  using standard molecular 
cloning techniques (126).  Restriction enzymes, T4 ligase, and Taq DNA polymerase 
were used according to the manufacturer’s instructions (NEB, Ipswich, MA).  PCR 
primers are listed in Table 2.  Electocompetent E. coli MC1061 and TOP10 were 
prepared and transformed according to standard methods (127).  L. acidophilus and L. 
gasseri were transformed using the method of Luchansky et al (128), while L. 
gallinarum was transformed a using the method of Beasley et al (129). 
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2.2.3 Recombinant Phytase Expression in Lactobacillus   
The phyA gene from B. subtilis (130) was codon optimized for expression in L. 
acidophilus using the OPTIMIZER web server (131) and commercially synthesized with 
EcoRI and NotI restriction sites to facilitate cloning.  The synthetic DNA sequence was 
provided by the manufacturer (Life Technologies, Inc. Carlsbad, CA) in a plasmid 
(pTD001).  The synthetic phyA gene was isolated from pTD001 and ligated into 
pTRK882 (109) for constitutive high-level expression in Lactobacillus.  The resulting 
plasmid, pTD003, was transformed into and subsequently propagated in E. coli MC-
1061.  The plasmids pTD003 and pTRK882were introduced into Lactobacillus species 
by electrotransformation.  Transformations were confirmed by PCR using gene specific 
primers (Table 2).  
2.2.4 SDS-PAGE 
  Supernatants from overnight Lactobacillus cultures were concentrated and 
purified by dialysis using Microsep advanced centrifugal devices (Pall Corporation, Ann 
Arbor, MI).  Total protein was precipitated using 100 % (w/v) trichloroacetic acid (TCA) 
(Sigma-Aldrich) and pelleted by centrifugation.  Protein pellets were washed 3 times 
using 80 % (w/v) acetone and resuspended in PBS. Protein concentration was 
determined using the Bradford method (132).  Protein was separated by SDS-PAGE 
using Mini-PROTEAN TGX Precast protein gels (any kD) (Bio-Rad Laboratories, 
Hercules, CA) in Tris-Glycine-SDS Buffer (Bio-Rad) with a low range protein standard 
(Bio-rad).  Wells were loaded with 3.5 µg of protein in Laemmli buffer (133).  Gels 
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were stained with GelCode Blue Safe Protein Stain (Thermo Scientific, Waltham, MA) 
for visualization of protein. 
2.2.5 Phytate Hydrolysis   
Phytate hydrolysis by Lactobacillus transformants was observed using a 
modification of the method of Bae et al (134).  Lactobacillus colonies were selected and 
aseptically transferred onto the surface of MRS agar plates (5µg/mL Erm) and incubated 
for 36 hours.  Plates were then overlaid with modified MRS (135), in which is 0.5% 
(w/v) sodium phytate (Pfaltz & Bauer, Waterbury, CT) was the sole phosphorus source 
and incubated for an additional 24 hours.  Plates were stained with cobalt chloride 
solution and counterstained with an ammonium molybdovanadate solution.  Phytate 
hydrolysis is indicated by zones of clearing. 
2.2.6 Phytase Enzyme Activity Assays 
  Phytase activity from cell free extracts (CFE) of recombinant Lactobacillus 
cultures was assayed by determining the amount of inorganic phosphate released from 
sodium phytate in phytase reaction buffer (6.4 mM sodium phytate, 2 mM CaCl2, 100 
mM Tris-HCl, pH 7.0) at 55°C.  Enzyme reactions were terminated by the addition of an 
equal volume of 5 % (w/v) TCA and free phosphate was determined colorimetrically 
(620 nm) using the ammonium molybdate method (136) with a sodium phosphate 
standard.  CFEs were prepared (109) in phytase extract buffer (2 mM CaCl2, 100 mM 
Tris-HCl, pH 7.0) as described previously.  Protein concentrations were determined 
using the Bradford method (132).  Phytase specific activity was reported as U mg
-1
 total 
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protein (µmol 
–
PO4 released min
-1
 mg
-1
).  Data were analyzed using ANOVA and 
significantly different means were determined using Duncan’s multiple range test. 
2.2.7 Broiler Chickens   
On day-of-hatch, male broiler chicks (Ross × Ross) were obtained from a 
commercial hatchery, individually weighed, wing banded, and assigned to pens based on 
body weight to ensure all treatment groups began with statistically similar weights.  
Broiler chicks were housed in battery brooders and given access to water and 
experimental rations ad libitum.  All experimental procedures were performed in 
accordance with protocols approved by the Texas A&M University Institutional Animal 
Care and Use Committee (IACUC). 
2.2.8 Broiler Performance Trial  
A total of 144 broiler chicks were separated into 6 treatment groups of 24 birds 
each.  Four experimental treatment groups were fed a phosphorus deficient diet (0.25% 
aP) and administered recombinant Lactobacillus cultures in Maximum Recovery Diluent 
(MRD) by oral gavage.  Chicks were administered L. gallinarum TDCC 63 (rPhyA
+
), L. 
gallinarum TDCC 62 (empty vector), L. gasseri TDCC 65 (rPhyA
+
), and L. gasseri 
TDCC 64 (Empty Vector).  Control groups were administered a mock inoculation 
(sterile MRD) and fed a phosphorus adequate diet (0.40% aP) (positive control) or the 
phosphorus deficient diet (0.25% aP) (negative control).  Broiler chicks were weighed 
individually at Day 0,7,14, and 21 post-hatch.  Data were analyzed using ANOVA and 
significant difference between treatment groups determined using Duncan’s multiple 
range test using individual birds as the experimental unit. 
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2.2.9 Experimental Diets 
A phosphorus deficient basal starter diet was formulated with 0.25 % available 
phosphate (aP) and all other nutrients meeting or exceeding or exceeding industry type 
broiler diet requirements for market broilers for Days 0-21 post-hatch (Table 3).  The 
positive control phosphorus adequate diet was formulated by increasing aP to 0.40 % 
with the addition of KH2PO4 to the basal diet.  Feed samples were analyzed by an 
independent laboratory for total phosphorus, calcium, and protein to confirm nutrient 
profile. 
2.3 RESULTS 
2.3.1 Recombinant Phytase Expression in Lactobacillus  
 The 1,149 bp phyA (BSU19800) gene encoding a phytase (76) from B. subtilis 
(130) was selected for recombinant expression in Lactobacillus.  Protein domain 
analysis of the 382 amino acid sequence predicted the presence of a Gram-positive 
signal peptide (Amino Acids 1 - 26) suggesting the protein would likely be secreted via 
the sec pathway (137).  B. subtilis phyA was codon optimized for expression in 
Lactobacillus using OPTIMIZER (131).  Before optimization, the codon adaptation 
index of the native phyA sequence was 0.27 and improved to 1.00 after optimization.  
The optimized sequence was commercially synthesized and subcloned into pTRK882.  
The resulting plasmid, pTD003 (Figure 1), and the empty vector, pTRK882 , were 
transformed into L. acidophilus NCFM, L. gallinarum ATCC 33319
T
, L. gasseri ATCC 
33323
T
.  Transformations were confirmed by PCR to detect ermC and recombinant phyA 
(rphyA) (data not shown).  Amplification of both phyA and ermC indicated successful 
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transformation by pTD003 and, amplification of ermC alone indicated successful 
transformation by pTRK882. 
2.3.2 SDS-PAGE   
Total protein in culture supernatants from Lactobacillus cultures was separated 
using SDS PAGE (Figure 2).  A protein with a molecular weight approximately 44 kDa 
was present in supernatants of L. acidophilus TDCC 61, L. gallinarum TDCC 63, and L. 
gasseri TDCC 65.  While a faint protein band of similar molecular weight did appear in 
the supernatant of L. gasseri TDCC 64, this protein was not detected in supernatants of 
the empty vector controls, L. acidophilus TDCC 60 and L. gallinarum TDCC 62.  The 
molecular weight of the secreted mature phytase from B. subtilis is 44kDa (76).  These 
data suggest that recombinant PhyA phytase (rPhyA) is expressed and secreted by 
Lactobacillus cultures transformed with pTD003. 
2.3.3 Phytate Hydrolysis  
Phytate hydrolysis by Lactobacillus cultures was evaluated qualitatively (Figure 
3).  Zones of clearing appeared around colonies of pTD003 transformed cultures, L. 
acidophilus TDCC 61, L. gallinarum TDCC 63, and L. gasseri TDCC 65.  However, 
little to no clearing appeared around colonies of the empty vector control cultures, L. 
acidophilus TD 60, L. gallinarum TDCC 62, and L. gasseri TDCC 64. 
2.3.4 Phytase Activity of Recombinant Lactobacillus Cultures  
 Phytase activity from cell pellets of recombinant Lactobacillus cultures was 
evaluated (Table 4).  Phytase activity of L. acidophilus TDCC 61, L. gallinarum TDCC 
63, and L. gasseri TDCC 65 was approximately 4-, 18-, and 10-fold, greater than the 
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respective empty vector control cultures.  Lactobacillus empty vector (pTRK882) 
transformants are wild-type for phytase activity and account for background phytate 
degradation by non-specific phosphatases.  Phytase activity of L. gallinarum TDCC 63 
and, L. gasseri TDCC 65 was approximately 2 and 3 times greater, respectively, than L. 
acidophilus TDCC 61. 
2.3.5 Broiler Performance Trial  
The effect of rPhyA producing Lactobacillus cultures on the performance of 
broiler chicks was evaluated (Figure 4).  There were no differences in body weight 
between the treatment groups at Day 0 and Day 7 post-hatch.  For mock inoculated 
treatment groups, the body weight of chicks fed a phosphorus adequate diet (positive 
control) was greater than those fed a phosphorus deficient diet (negative control) at Day 
14 and 21 post-hatch (P<0.05).  The body weight of chicks administered PhyA 
producing L. gallinarum (TDCC 63) and L. gasseri (TDCC 65) was not significantly 
different than those administered the respective empty vector control cultures, L. 
gallinarum TDCC 62 and L. gasseri TDCC 64, or the negative control group.  However, 
the body weight of chicks administered L. gasseri TDCC 65 was not significantly 
different than the positive control group.  While performance was not significantly 
increased compared to the negative control or relevant empty vector control the 
administration of rPhyA producing L. gasseri improved weight gain of broiler chickens 
to a level statistically comparable to chicks fed a phosphorus adequate diet. 
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2.4 DISCUSSION 
The objective of this study was to investigate phytate degradation as a novel 
mechanism of probiotic functionality.  An important role of the gastrointestinal 
microbiota is to indirectly augment host metabolism by utilizing undigested food and 
producing short chain fatty acids and micronutrients which can be utilized by the host 
(79).  The microbial origin of exogenous enzymes used in livestock production, 
including phytases, suggests that direct augmentation of host metabolism through the 
production and delivery of these enzymes in situ may be an important mechanism of 
probiotic functionality.  While these enzyme activities have been suggested as selection 
criteria for probiotic cultures (135, 138), biocatalysis by probiotics in the gastrointestinal 
tract has not been explored. 
Phytate-degrading activity has been reported in Lactobacillus species and has 
been suggested to improve nutritional quality of fermented cereal grains (139-141).  De 
Angelis et al. (142) reported the purification of a phytase from Lactobacillus 
sanfranciscensis.  However, the significantly greater substrate specificity of this enzyme 
towards p-nitrophenyl phosphate over phytate suggests this enzyme would more 
appropriately be classified as a non-phytate specific acid phosphatase.  Phytate 
degradation has been attributed to non-specific acid phosphatases in other lactobacilli 
(143, 144).  Additionally, a phytase gene has not yet been identified in a Lactobacillus 
species.  
Because true phytase-producing Lactobacillus cultures have not yet been 
identified, recombinant cultures were used to model phytate degradation by probiotic 
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microbes.  Recombinant expression of exogenous phytase in Lactobacillus has been 
previously investigated (145, 146).  However, our approach to the expression of 
exogenous phytase is novel in that we have maximized expression using pTRK882, 
which is under control of the constitutive high-expressing promoter Ppgm from L. 
acidophilus NCFM (109), and codon optimized the sequence of our recombinant phytase 
gene for expression in Lactobacillus species.  This expression system was previously 
demonstrated to be effective in enzyme expression (109), the production and delivery of 
immune modulating cytokines (147), and an anthrax vaccine (106).  Additionally, its 
wide host range allowed the transformation of L. acidophilus, L. gallinarum, and L. 
gasseri.  
The phyA gene from B. subtilis (130) encodes a β-propeller phytase with high 
specificity for phytic acid and activity over broad pH and temperature ranges (76).  
Analysis of the amino acid sequence using SignalP (137) predicted the presence of a 
Gram-positive secretion signal suggesting that heterologous expression of this protein in 
Lactobacillus will result in production of a secreted protein.  Thus, we selected the B. 
subtilis phyA for expression in Lactobacillus. Interestingly, the popularity of probiotic 
and DFM products containing spore-forming bacteria including B. subtilis has increased 
(148-151).  Bacillus species are workhorse bacteria in microbial fermentations and 
highly prized as producers of industrially important enzymes (152).  Heterologous 
expression of B. subtilis phytase using Lactobacillus in this study not only demonstrates 
biocatalytic phytate degradation as a general mechanism of probiotic functionality but 
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will guide future studies investigating this specific mechanism in Bacillus species further 
supporting their use in probiotic and DFM products. 
Phytase was expressed recombinantly using L. acidophilus NCFM, L. gallinarum 
ATCC 33319, and L. gasseri ATCC 33323.  Both L. acidophilus and L. gasseri cultures 
used in this study were originally isolated from the human gastrointestinal tract (153, 
154).  They are commonly used as model organisms in research investigating 
mechanisms of probiotic functionality because they are readily transformed (155, 156), 
genetically tractable (109, 157), and the availability of the complete genome sequences 
(158, 159) for these microorganisms.  L. gallinarum was originally isolated from the 
crop of a chicken (160) and has been demonstrated to reduce gastrointestinal 
colonization of Campylobacter jeuni in experimentally challenged broiler chickens 
(116).  Transformation and heterologous protein expression in L. gallinarum ATCC 
33319 has not been reported previously. 
SDS-PAGE revealed the presence of a protein with a molecular weight similar to 
B. subtilis phytase (76) in the supernatants of L. acidophilus TDCC 61, L. gallinarum 
TDCC 63, and L. gasseri TDCC 65, which was likely to be recombinant PhyA expressed 
using pTD003.  Additionally, a protein of similar molecular weight was also present in 
the supernatant of the empty vector control culture L. gasseri TDCC 64.  The LAB-
Secretome DB (161) predicted  three secreted proteins expressed by L. gasseri ATCC 
33323 with molecular weights between 39 kDa and 51 kDa, which may be the protein 
present.  
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Differential media containing phytate are commonly used to detect phytase 
activity (134, 135, 162).  Phytase activity is indicated by zones of clearing around 
colonies cultured using phytate containing media.  However, reduced pH around 
colonies of acid producing bacteria may also cause the appearance of zones of clearing.  
False positive detection of  phytase activity can be reduced by staining with aqueous 
cobalt chloride and ammonium molybdovanadate solutions (134).  Staining of 
differential screening plates requires colonies to be washed from the plate surface prior 
to detection of enzymatic activity (134, 135).  In this study, an overlay medium (104) 
containing phytate was used to remove the need to wash colonies from the plate surface.  
This modification is expected to facilitate future screening for phytate-degrading 
Lactobacillus cultures by allowing isolates to be picked through the overlay agar for 
subculture.  
Recombinant expression of phytase in Lactobacillus cultures has previously been 
reported (145, 146).  However, comparison with previously reported results was 
impossible because activity was not evaluated (146) or specific activity was not reported 
(145).  Comparison with published studies of wild-type Lactobacillus cultures was also 
complicated because specific activity was not reported (135) or reported in non-standard 
units (142, 144, 163).  Nonetheless, we have determined our recombinant cultures 
produce 10-50 fold greater activity than previously reported for wild-type lactobacilli 
(135, 142, 144, 163). 
L. gallinarum TDCC 63 and L. gasseri TDCC 65 were selected for 
administration to broiler chicks because they produced greater phytase activity than L. 
 29 
 
acidophilus TDCC 61(Figure 4).  Because colonization by allochthonous lactobacilli is 
transient, the probiotic cultures were administered daily (164) in order to maintain high 
levels of administered lactobacilli in the gastrointestinal tract of the experimental 
animals.  While the probiotic potential of phytate-degrading Lactobacillus cultures has 
been explored previously (135, 138, 145), this is the first study to evaluate the effect of 
their administration in vivo.  Supplementation with commercial phytase improved 3-
week weight gain of broilers fed a phosphorus deficient diet (0.27 % aP) to a level 
similar to broilers fed a phosphorus adequate diet (0.47 % aP) (165).  It is generally 
accepted that the aP content of broiler chicken rations supplemented with commercial 
phytases can be reduced by 0.1% or more without a significant decrease in weight gain 
(18, 166).  Body weight gain of chicks administered L. gasseri TDCC 65 (rPhyA
+
) was 
not significantly greater than other groups fed a phosphorus deficient diet.   However, 
weight gain was improved to a level statistically comparable to the phosphorus adequate 
control group.  Similar results were seen in early pilot studies investigating 
supplementation with a crude phytase preparation (167).  While the increased 
performance of chicks administered L. gasseri TDCC 65 over negative and empty vector 
control groups was not significant, this study demonstrates proof of principle of in situ 
phytate-degradation as probiotic functionality.  Further improvement of increased 
growth performance is expected in future studies.  
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CHAPTER III 
CONCLUSION 
 
Using recombinant expression of B. subtilis phytase in Lactobacillus cultures, we 
have demonstrated that administration of phytate-degrading probiotic cultures can 
improve performance of non-ruminant livestock animals fed a phosphorus deficient diet.  
While phytate-degradation by Lactobacillus reported previously was attributed to non-
specific phosphatases, a sufficiently large screen may identify Lactobacillus cultures 
expressing this desired activity.  Alternatively, true specific phytase activity may not be 
critical if sufficient phytate-degradation can be produced from non-specific 
phosphatases.  The use of recombinant microorganisms allowed us to investigate this 
novel mechanism and inform future studies to identify and investigate wild-type 
probiotic microorganisms able to improve utilization of phytate and other indigestible 
feed constituents.  We have demonstrated proof of principle of in situ degradation of 
indigestible feed constituents in the gastrointestinal tract as a novel mechanism of 
probiotic functionality.  Feed additive enzyme supplementation and probiotic 
administration are widely used in livestock management programs.  The development of 
probiotic cultures able to provide the nutritional and performance benefits of feed 
additive enzymes and the animal health and food safety benefits traditionally associated 
with probiotics is expected to benefit livestock production. 
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APPENDIX A 
 
 
  
Table 1. Bacterial Strains and Plasmids Used in This study 
Strain or plasmid Relevant Characterisitcs Source or Reference 
L. acidophilus   
    NCFM Human intestinal isolate (158) 
    TDCC 60 NCFM with pTRK882 This study 
    TDCC 61 rPhyA
+
, NCFM with pTD003 This study 
L. gallinarum   
    ATCC 33319
T 
Chicken crop isolate, type strain ATCC
 
    TDCC 62 ATCC 33319 with pTRK882 This study 
    TDCC 63 rPhyA
+
, ATCC 33319 with pTD003 This study 
L. gasseri   
    ATCC 33323
T 
Human isolate, type strain (159) 
    TDCC 64 ATCC 33323 with pTRK882 This study 
    TDCC 65 rPhyA+, ATCC 33323 with pTD003 This study 
E. coli   
    MC1061 Str
r
, E.coli transformation host (124) 
    TOP10 Str
r
, E.coli transformation host Invitrogen 
    NCK1814  MC1061 with pTRK882 (109) 
    TDCC 33 TOP10 with pTD001 This study 
    TDCC 66 MC1061 with pTD003 This study 
Plasmids   
    pTRK882 4.4kb, Erm
r
, constitutive expression vector, Ppgm (109) 
    pTD001 3.5kb, Amp
r
, pMAT::phyA This study 
    pTD003 5.6kb, Erm
r
, pTRK882::phyA This study 
ATCC =American Type Culture Collection; T= Type Culture 
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Table 2. PCR Primers 
Target 
Gene 
Primer Sequence (5’→ 3’) 
ermC pGK12_ermF ATTCTCTTGGAACCATAC 
 pGK12_ermR ACTGCCATTGAAATAGAC 
phyA phy_1258F ATTATCAACTGCTGCTGGTT 
 phy_1976R ATCAACAACTTGACCCTTTG 
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Table 3. Ingredient Profile and Nutrient Concentration of 
the Basal Starter Diet 
Ingredient Percentage 
Corn 60.03 
Soybean Meal (48% Crude Protein) 34.14 
Limestone 1.70 
Sodium Chloride 0.46 
Fat (Animal/Vegetable Blend) 2.24 
L-Lysine HCl 0.17 
DL-Methionine (99%) 0.26 
Vitamins
1
 0.25 
Minerals
2
 0.05 
Monocalcium PO4 0.60 
L-Threonine 0.03 
Calculated Nutrient Concentration  
Crude Protein (%) 22.00 
Metabolizable Energy (kcal/kg) 3,050 
Methionine (%) 0.58 
Total Sulfur Amino Acids (%) 0.95 
Lysine (%) 1.30 
Threonine (%) 0.85 
Tryptophan (%) 0.26 
Calcium 0.85 
Sodium 0.20 
Total Phosphorus
 
0.50 
Available Phosphorus 0.25 
1 Vitamin premix added at this rate yields 11,023 IU vitamin A, 3,858 IU 
vitamin D3, 46 IU vitamin E, 0.0165 mg B12, 5.845 mg riboflavin, 45.93 
mg niacin, 20.21 mg d-pantothenic acid, 477.67 mg choline, 1.47 mg 
menadione, 1.75 mg folic acid, 7.17 mg pyroxidine, 2.94 mg thiamine, 
0.55 mg biotin per kg diet.  The carrier is ground rice hulls. 
2 Trace mineral premix added at this rate yields 149.6 mg manganese, 
125.1 mg zinc, 16.5 mg iron, 1.7 mg copper, 1.05 mg iodine, .25 mg 
selenium, a minimum of 6.27 mg calcium, and a maximum of 8.69 mg 
calcium per kg of diet.  The carrier is calcium carbonate and the premix 
contains less than 1% mineral oil. 
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Table 4. Phytase Activity of Recombinant Lactobacillus Cultures 
 Specific Activity (U/mg)
1 
Activity
 
Cultures pTD003 pTRK882  Increase
2
 
L. acidophilus 0.168±0.019
c 
0.046±0.029
d 
4.04±2.46
c
 
L. gallinarum 0.556±0.077
a
 0.034±0.011
d 
18.61±5.80
a
 
L. gasseri 0.387±0.041
b
 0.038±0.003
d 
10.68±0.33
b
 
1 Units; International Units, µmol –PO4 released min-1 mg-1total protein;-2 Fold increase 
between pTD003 (rPhyA+) and pTD882 (empty vector) transformed cultures; Error bars 
represent the SEM of replicate reactions from three independent assays.a-c different 
superscripts within columns indicate the means differ significantly (P<0.05) 
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Figure 1. Plasmid Map of pTD003 
Black arrows, replication determinants; light gray arrows, erythromycin 
resistance marker, ermC; black boxes, transcriptional terminators; white arrow, Ppgm 
promoter; dark gray arrow, codon optimized phytase gene, phyA. 
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Figure 2.  SDS-PAGE   
Supernatants from Lactobacillus cultures were analyzed using SDS-PAGE. Lane 
1, L. acidophilus TDCC 61; Lane 2, L. acidophilus TDCC 60, Lane 3, L. gallinarum 
TDCC 63; Lane 4, L. gallinarum TDCC 62, Lane 5, L. gasseri TDCC 65, Lane 6, L. 
gasseri TDCC 64; M, low range molecular weight marker.   
 
 
 
 
 
 
 
 
 
 
 
 
Lane
Strain
+
-
+
-
-
+
-
+
pTD003
pTRK882
1 2 3 4 5 6
L. acidophilus L. gallinarum L. gasseri
97.4 kDa
21.5 kDa
31.0 kDa
45.0 kDa
66.2 kDa
M
-
+
+
-
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Figure 3.  Phytate Hydrolysis   
Lactobacillus cultures were spotted onto MRS agar and incubated 36 hours.  
Plates were overlaid with modified MRS agar with 0.5% sodium phytate and incubated 
24 hours.  Plates were stained with cobalt chloride solution and counterstained with 
ammonium molybdovanadate solution. Zones of clearing indicate phytate hydrolysis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
L. acidophilus 
L. gallinarum 
L. gasseri 
pTD003 pTRK882 
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Figure 4. Average Body Weights of Broiler Chicks   
Male broiler chicks were divided between six treatment groups and fed either a 
phosphorus adequate control diet (0.40% aP) or a phosphorus deficient diet (0.25% aP) 
and administered either a mock inoculation (MRD) or cultures of L. gallinarum and L. 
gasseri by oral gavage daily.  Broiler chicks were weighed individually at Day 0, 7, 14, 
and 21 post-hatch.  Data are shown as the mean body weight for each treatment group 
and error bars represent the SEM.  Different letters indicate means are significantly 
different.  
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APPENDIX B 
 
Supplemental Table 1.  Average Body and Tibia Weights of Broiler Chicks 
 Male broiler chicks were divided between six treatment groups and fed either a 
phosphorus adequate control diet (0.40% aP) or a phosphorus deficient diet (0.25% aP) 
and administered either a mock inoculation (MRD) or cultures of L. gallinarum and L. 
gasseri by oral gavage daily.  Broiler chicks were weighed individually at Day 0, 7, 14, 
and 21 post-hatch. Right tibia was collected from each bird for bone ashing.  Data are 
shown as the mean body weight and ash weight for each treatment group and error bars 
represent the SEM.  Different letters indicate means are significantly different. 
 
Supplemental Table 1.  Performance of Male Broiler Chicks Administered Recombinant Lactobacillus Cultures 
Diet P-Adequate P-Deficient P-Deficient P-Deficient P-Deficient P-Deficient 
aP%1 0.40% 0.25% 0.25% 0.25% 0.25% 0.25% 
Strain2 - - 
L. gallinarum L. gasseri 
pTD003 pTRK882 pTD003 pTRK882 
Weight (g)       
Day 0 46.0±2.2 47.0±2.0 46.0±3.2 46.3±3.2 46.8±2.4 45.7±2.4 
Day 7 170.8±20.2 166.4±14.6 164.3±13.9 166.8±16.8 170.9±15.8 165.7±14.7 
Day 14 434.1±55.5a 388.1±57.8b 382.4±49.7b 402.1±42.6b 406.1±36.9a,b 386.5±54.4b 
Day 21 822.6±120.0a 719.3±120.7b 688.4±109.5b 741.3±90.3b 760.7±77.2a,b 716.5±154.4 b 
Bone Ash 
(%) 
45.90±0.62a 40.11±0.34b 40.32±0.17b 40.41±1.76b 39.99±1.59b 38.72±2.60b 
1Available phosphate; 2Bacterial strain administered; a-b Different superscripts within rows indicates means differ 
significantly (P<0.05) 
 
 
 
